Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M Connor

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Pediatrics|October 1, 1986
Neurologic manifestations of human immunodeficiency virus infection in childrenL G Epstein, L R Sharer, J M Oleske, et al.
Pediatrics|September 1, 1988
Primary lymphoma of the central nervous system in children with acquired immunodeficiency syndromeL G Esptein, F J DiCarlo, V V Joshi, et al.
The New England Journal of Medicine|November 3, 1994
Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study GroupE M Connor, R S Sperling, R Gelber, et al.
The New England Journal of Medicine|April 21, 1991
A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study GroupR E McKinney, M A Maha, E M Connor, et al.
The New England Journal of Medicine|November 3, 1994
A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials GroupS A Spector, R D Gelber, N McGrath, et al.
Pediatrics|December 1, 1988
Persistent human immunodeficiency virus type 1 antigenemia in children correlates with disease progressionL G Epstein, C A Boucher, S H Morrison, et al.
Vaccine|March 6, 1999
Safety and immunogenicity of recombinant Bacille Calmette-Guérin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccineR Edelman, K Palmer, K G Russ, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Pediatrics|October 1, 1986
Neurologic manifestations of human immunodeficiency virus infection in childrenL G Epstein, L R Sharer, J M Oleske, et al.
Pediatrics|September 1, 1988
Primary lymphoma of the central nervous system in children with acquired immunodeficiency syndromeL G Esptein, F J DiCarlo, V V Joshi, et al.
The New England Journal of Medicine|November 3, 1994
Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study GroupE M Connor, R S Sperling, R Gelber, et al.
The New England Journal of Medicine|April 21, 1991
A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study GroupR E McKinney, M A Maha, E M Connor, et al.
The New England Journal of Medicine|November 3, 1994
A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials GroupS A Spector, R D Gelber, N McGrath, et al.
Pediatrics|December 1, 1988
Persistent human immunodeficiency virus type 1 antigenemia in children correlates with disease progressionL G Epstein, C A Boucher, S H Morrison, et al.
Vaccine|March 6, 1999
Safety and immunogenicity of recombinant Bacille Calmette-Guérin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccineR Edelman, K Palmer, K G Russ, et al.
Pageof 3